Is there any rule for antiviral therapy in HBV-related compensated cirrhosis patients with serum HBV DNA undetectable or at low levels and normal ALT?

被引：0
|
作者：
Yan, Taotao [1 ]
Sha, Xiaoying [3 ]
Wang, Jing [1 ]
Jin, Li [1 ]
Zhang, Yu [2 ]
Yi, Ruitian [1 ]
Cao, Furong [1 ]
Yang, Yuan [2 ]
Liu, Jinfeng [2 ]
He, Yingli [2 ]
Chen, Tianyan [2 ]
Zhao, Yingren [2 ]
机构：
[1] Xi An Jiao Tong Univ, Xian 710049, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, Xian 710049, Peoples R China
[3] Eighth Hosp Xian, Dept Infect Dis, Xian, Peoples R China
来源：
HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1541
引用
收藏
页码：961A / 962A
页数：3
相关论文
共 50 条
  • [21] Prediction of liver-related events in patients with compensated HBV-induced cirrhosis receiving antiviral therapy
    Wu, Xiaoning
    Zhou, Jialing
    Sun, Yameng
    Ding, Huiguo
    Chen, Guofeng
    Xie, Wen
    Piao, Hongxin
    Xu, Xiaoyuan
    Jiang, Wei
    Ma, Hui
    Ma, Anlin
    Chen, Yongpeng
    Xu, Mingyi
    Cheng, Jilin
    Xu, Youqing
    Meng, Tongtong
    Wang, Bingqiong
    Chen, Shuyan
    Shi, Yiwen
    Kong, Yuanyuan
    Ou, Xiaojuan
    You, Hong
    Jia, Jidong
    HEPATOLOGY INTERNATIONAL, 2021, 15 (01) : 82 - 92
  • [22] ANALYZING HBV-DNA IN LIVER TISSUE FOR INVESTIGATION OF UNEXPLAINED ALT ELEVATION IN HBSAG POSITIVE PATIENTS WITH UNDETECTABLE SERUM HBV-DNA
    Eyigunl, Can P.
    Coskun, Omer
    Gul, Hanefi C.
    Gunal, Emine
    Kubar, Ayhon
    Avci, Ismail Y.
    Erdem, Hakon
    Besirbellioglu, Bulent A.
    Gorenek, Levent
    HEPATOLOGY, 2008, 48 (04) : 536A - 537A
  • [23] High CONUT score predicts poor survival and postoperative HBV reactivation in HBV-related hepatocellular carcinoma patients with low HBV-DNA levels
    Wang, Xiao-Bo
    Chen, Jie
    Xiang, Bang-De
    Wu, Fei-Xiang
    Li, Le-Qun
    EJSO, 2019, 45 (05): : 782 - 787
  • [24] Values of Serum HBsAg and HBeAg Levels for Virological Response of Patients with HBV-Related Liver Cirrhosis Treated by Entecavir
    Gong, Xuyang
    Chen, Zhitao
    Zhang, Xiaoxia
    Zheng, Yi
    Zhang, Heng
    CLINICAL LABORATORY, 2023, 69 (06) : 1185 - 1193
  • [25] Increased Serum Levels of sCD206 Are Associated with Adverse Prognosis in Patients with HBV-Related Decompensated Cirrhosis
    Zhang, Yue
    Xiao, Nanxi
    Liu, Qi
    Nie, Yuan
    Zhu, Xuan
    DISEASE MARKERS, 2022, 2022
  • [26] Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
    Zhu, Dong-Mei
    Xie, Jing
    Ye, Chun-Yan
    Qian, Mei-Yun
    Xue, Yuan
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020
  • [27] Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV–DNA level < 2000 IU/mL
    Hankil Lee
    Sungin Jang
    Sang Hoon Ahn
    Beom Kyung Kim
    Hepatology International, 2022, 16 : 294 - 305
  • [28] SERUM FERRITIN LEVELS IN PATIENTS WITH HBV AND HDV-RELATED CIRRHOSIS
    Olmez, Sehmus
    Aslan, Mehmet
    Saritas, Bunyamin
    Yalcin, Mehmet Suat
    Tas, Adnan
    Balaharoglu, Ragip
    ACTA MEDICA MEDITERRANEA, 2016, 32 (06): : 1813 - 1819
  • [29] A high baseline HBV load and antiviral therapy affect the survival of patients with advanced HBV-related HCC treated with sorafenib
    Yang, Yu
    Wen, Feng
    Li, Jianliang
    Zhang, Pengfei
    Yan, Wenhui
    Hao, Ping
    Xia, Feng
    Bi, Feng
    Li, Qiu
    LIVER INTERNATIONAL, 2015, 35 (09) : 2147 - 2154
  • [30] ANTIVIRAL THERAPY IMPROVES LONG-TERM HEALTH RELATED QUALITY OF LIFE IN COMPENSATED HBV-CIRRHOSIS PATIENTS
    Wu, Xiaoning
    Hong, Jia
    Zhou, Jialing
    Sun, Yameng
    Ding, Huiguo
    Xie, Wen
    Piao, Hongxin
    Xu, Xiaoyuan
    Jiang, Wei
    Feng, Bo
    Xu, Mingyi
    Cheng, Jilin
    Ou, Xiaojuan
    Jia, Jidong
    You, Hong
    HEPATOLOGY, 2020, 72 : 453A - 453A
12345